Trends in Biochemical Sciences 2004-02-01

The glamour and gloom of glycogen synthase kinase-3.

Richard S Jope, Gail V W Johnson

Index: Trends Biochem. Sci. 29(2) , 95-102, (2004)

Full Text: HTML

Abstract

Glycogen synthase kinase-3 (GSK3) is now recognized as a key component of a surprisingly large number of cellular processes and diseases. Several mechanisms play a part in controlling the actions of GSK3, including phosphorylation, protein complex formation, and subcellular distribution. These are used to control and direct the far-reaching influences of GSK3 on cellular structure, growth, motility and apoptosis. Dysregulation of GSK3 is linked to several prevalent pathological conditions, such as diabetes and/or insulin resistance, and Alzheimer's disease. Therefore, much effort is currently directed towards understanding the functions and control of GSK3, and identifying methods capable of diminishing the deleterious impact of GSK3 in pathological conditions.


Related Compounds

Related Articles:

Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors.

2015-06-17

[ACS Chem. Neurosci. 6 , 911-9, (2015)]

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

2000-07-06

[Nature 406(6791) , 86-90, (2000)]

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.

1998-11-15

[Genes Dev. 12(22) , 3499-511, (1998)]

Progesterone receptor A stability is mediated by glycogen synthase kinase-3β in the Brca1-deficient mammary gland.

2013-09-06

[J. Biol. Chem. 288(36) , 26265-74, (2013)]

N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation.

2007-08-03

[J. Biol. Chem. 282(31) , 22406-13, (2007)]

More Articles...